Shaanxi Panlong Pharmaceutical Group Co., Ltd. (SHE:002864)

Market Cap	2.91B +0.1%
Revenue (ttm)	1.11B +9.8%
Net Income	86.79M -27.9%
EPS	0.83 -27.8%
Shares Out	105.91M
PE Ratio	33.03
Forward PE	n/a
Dividend	0.35 (1.25%)
Ex-Dividend Date	n/a

Volume	1,243,336
Open	28.10
Previous Close	27.43
Day's Range	26.66 - 28.10
52-Week Range	26.66 - 42.88
Beta	-0.23
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 24, 2026

About SHE:002864

Shaanxi Panlong Pharmaceutical Group Co., Ltd. researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. The company was formerly known as Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd and changed its name to Shaanx...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 926
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002864

Financial Performance

In 2025, SHE:002864's revenue was 1.14 billion, an increase of 17.15% compared to the previous year's 973.86 million. Earnings were 96.28 million, a decrease of -19.95%.